Lung tissues have been stained with hematoxylin and eosin.
PS09
Antiinflamm. Antiallergy Agents Med. Chem. 2022, 21, 135-151.
Effects of acylhydrazone derivatives on experimental pulmonary inflammation by chemical sensitization.
https://doi.org/10.2174/1871523021666220729141608
Flow chart of the study.
PS08
J. Infect. Dis. 2022, 225, 868-880.
PRONOCYSTIS Study Group. Epidemiology and clinical impact of respiratory cinfections at diagnosis of Pneumocystis jirovecii pneumonia.
https://doi.org/10.1093/infdis/jiab460
Single-nucleotide polymorphisms in Pneumocystis jirovecii hot spot 1 (HS1) and HS2 DNA regions after sequencing.
PS07
Antimicrob. Agents Chemother. 2022, 66, e0156321.
Highly conserved gsc1 gene of Pneumocystis jirovecii in patients with or without prior exposure to ehinocandins.
https://doi.org/10.1128/AAC.01563-21
PS06
Parasite. 2022, 29.
Selecting a multiplex PCR panel for accurate molecular diagnosis of intestinal protists: a comparative study of Allplex® (Seegene®), G-DiaParaTrio (Diagenode®), and RIDA®GENE (R-Biopharm®) assays and microscopic examination.
https://doi.org/10.1051/parasite/2022003
CYP3A activity at different level of inflammation.
PS05
Clin. Pharmacol. Ther. 2022, 112, 1033-1039.
Impact of inflammation on midazolam metabolism in severe COVID-19 Patients.
https://doi.org/10.1002/cpt.2698
Effect of isoxazoline-acyl hydrazone derivatives R-99 and R-123 (15 mg/kg, p.o.) and ruthenium red (3 mg/kg, i.p.) in capsaicin-induced nociception test in mice.
PS04
Curr. Top. Med. Chem. 2022, 22, 247-258.
Antinociceptive effects of aza-bicyclic isoxazoline-acylhydrazone derivatives in different models of nociception in mice.
https://doi.org/10.2174/1568026622666220105102508
cAMP functional assay. Effect of increasing concentrations of JM-00266 (A) or Rimonabant (B) on cAMP Glosensor luminescence in the absence or presence of anandamide (AEA; 0–1 µM).
PS03
Int. J. Mol. Sci. 2022, 23, 2923.
Chemical synthesis, pharmacokinetic properties and biological effects of JM-00266, a putative non-brain penetrant cannabinoid receptor 1 inverse agonist.
https://doi.org/10.3390/ijms23062923